LOBERG MICHAEL D 4
4 · IGM Biosciences, Inc. · Filed Oct 3, 2022
Insider Transaction Report
Form 4
LOBERG MICHAEL D
Director
Transactions
- Purchase
Common Stock
2022-09-29$19.62/sh+5,821$114,213→ 35,305 total(indirect: See footnote) - Award
Common Stock
2022-09-30+533→ 533 total
Holdings
- 43,143(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $19.36 to $19.80. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
- [F2]The shares are held by the Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
- [F4]The shares are held by the Michael D. Loberg Qualified Annuity Interest Trust IX (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.